Levels of Impulsivity, Hyperactivity, and Inattention and the Association with Mental Health and Substance Use Severity in Opioid-Dependent Patients Seeking Treatment with Extended-Release Naltrexone

The level of impulsivity, hyperactivity, and inattention (IHI) is higher among patients with substance use disorder (SUD) than in the general population. However, the prevalence of such symptoms in patients seeking treatment with an opioid antagonist, such as extended-release naltrexone (XR-NTX), is...

Descripción completa

Detalles Bibliográficos
Autores principales: Karlsson, Ann Tarja, Vederhus, John-Kåre, Clausen, Thomas, Weimand, Bente, Solli, Kristin Klemmetsby, Tanum, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509800/
https://www.ncbi.nlm.nih.gov/pubmed/34640572
http://dx.doi.org/10.3390/jcm10194558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509800/
https://www.ncbi.nlm.nih.gov/pubmed/34640572
http://dx.doi.org/10.3390/jcm10194558

Ejemplares similares